Rūta Veinalde

700 total citations
13 papers, 469 citations indexed

About

Rūta Veinalde is a scholar working on Genetics, Oncology and Epidemiology. According to data from OpenAlex, Rūta Veinalde has authored 13 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Rūta Veinalde's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (6 papers) and Virology and Viral Diseases (4 papers). Rūta Veinalde is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (6 papers) and Virology and Viral Diseases (4 papers). Rūta Veinalde collaborates with scholars based in Germany, Canada and Latvia. Rūta Veinalde's co-authors include Guy Ungerechts, Christine E. Engeland, Christof von Kalle, Dirk Jäger, Christian Grossardt, Sascha Bossow, Johanna K. Kaufmann, Ivan Shevchenko, Viktor Umansky and Dirk M. Nettelbeck and has published in prestigious journals such as Clinical Cancer Research, Frontiers in Immunology and Journal of General Virology.

In The Last Decade

Rūta Veinalde

13 papers receiving 462 citations

Peers

Rūta Veinalde
Karishma Rajani United States
Megha Shettigar United States
Janet Lei-Rossmann United Kingdom
Laetitia Fend France
Sarah Knocke Germany
Louise Medley United Kingdom
Rob Coffin United Kingdom
Amelia S. Aitken Canada
Abraham Anderson United States
Margaret R. Duffy United Kingdom
Karishma Rajani United States
Rūta Veinalde
Citations per year, relative to Rūta Veinalde Rūta Veinalde (= 1×) peers Karishma Rajani

Countries citing papers authored by Rūta Veinalde

Since Specialization
Citations

This map shows the geographic impact of Rūta Veinalde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rūta Veinalde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rūta Veinalde more than expected).

Fields of papers citing papers by Rūta Veinalde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rūta Veinalde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rūta Veinalde. The network helps show where Rūta Veinalde may publish in the future.

Co-authorship network of co-authors of Rūta Veinalde

This figure shows the co-authorship network connecting the top 25 collaborators of Rūta Veinalde. A scholar is included among the top collaborators of Rūta Veinalde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rūta Veinalde. Rūta Veinalde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Veinalde, Rūta, Gemma Pidelaserra-Martí, Chin Leng Tan, et al.. (2023). Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model. Frontiers in Immunology. 13. 1096162–1096162. 5 indexed citations
2.
Veinalde, Rūta, Gemma Pidelaserra-Martí, Lara M. Jeworowski, et al.. (2021). Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory. Molecular Therapy — Oncolytics. 24. 43–58. 13 indexed citations
3.
Veinalde, Rūta. (2019). Evaluation of Oncolytic Virus-Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models. Methods in molecular biology. 2058. 213–227. 3 indexed citations
4.
Backhaus, Philipp, Rūta Veinalde, Laura Hartmann, et al.. (2019). Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists. Viruses. 11(10). 914–914. 35 indexed citations
5.
Speck, Tobias, Rūta Veinalde, Dirk Jaeger, et al.. (2018). Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors. Clinical Cancer Research. 24(9). 2128–2137. 86 indexed citations
6.
Engeland, Christine E., Sascha Bossow, Andrew W. Hudacek, et al.. (2017). A Tupaia paramyxovirus vector system for targeting and transgene expression. Journal of General Virology. 98(9). 2248–2257. 5 indexed citations
7.
Veinalde, Rūta, Christian Grossardt, Laura Hartmann, et al.. (2017). Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation. OncoImmunology. 6(4). e1285992–e1285992. 61 indexed citations
8.
Veinalde, Rūta, Christian Grossardt, Marie‐Claude Bourgeois‐Daigneault, et al.. (2016). Abstract A068: Determinants of efficacy in cancer immunovirotherapy. Cancer Immunology Research. 4(11_Supplement). A068–A068. 1 indexed citations
9.
Engeland, Christine E., Rūta Veinalde, Christof von Kalle, Dirk Jaeger, & Guy Ungerechts. (2016). Abstract B128: Clinical translation of oncolytic measles virus for T cell activation. Cancer Immunology Research. 4(11_Supplement). B128–B128. 1 indexed citations
10.
Engeland, Christine E., Rūta Veinalde, Christof von Kalle, Dirk Jaeger, & Guy Ungerechts. (2016). 423. Clinical Translation of Immunovirotherapy: Measles Virus and Anti-PD1. Molecular Therapy. 24. S168–S168. 1 indexed citations
11.
Engeland, Christine E., Christian Grossardt, Rūta Veinalde, et al.. (2014). CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy. Molecular Therapy. 22(11). 1949–1959. 239 indexed citations
12.
13.
Veinalde, Rūta, et al.. (2013). Ex vivo cytokine production in peripheral blood mononuclear cells after their stimulation with dsRNA of natural origin. Biotechnology and Applied Biochemistry. 61(1). 65–73. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karishma Rajani Breakdown of academic impact, for papers by Megha Shettigar Breakdown of academic impact, for papers by Janet Lei-Rossmann Breakdown of academic impact, for papers by Laetitia Fend Breakdown of academic impact, for papers by Sarah Knocke Breakdown of academic impact, for papers by Louise Medley Breakdown of academic impact, for papers by Rob Coffin Breakdown of academic impact, for papers by Amelia S. Aitken Breakdown of academic impact, for papers by Abraham Anderson Breakdown of academic impact, for papers by Margaret R. Duffy
Rankless by CCL
2026